Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You search for a phrase ""Wu, Fan"" according to the criterion: Author


Title:
PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme.
Authors:
Huang L; Department of Pathophysiology, Beijing Neurosurgical Institute, Capital Medical University, China.
Wang Z; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Liao C; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Zhao Z; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Gao H; Department of Cell Biology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Huang R; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Chen J; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Wu F; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Zeng F; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Zhang Y; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Jiang T; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.; Chinese Glioma Genome Atlas Network and Asian Glioma Genome Atlas Network, Beijing, China.
Hu H; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Show more
Source:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Jan; Vol. 30 (1), pp. e14566.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glioblastoma*/pathology
Glioma*/genetics
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
MicroRNAs*/metabolism
Humans ; Cell Line, Tumor ; Macrophages/pathology ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Tumor Microenvironment ; STAT1 Transcription Factor/genetics ; STAT1 Transcription Factor/metabolism ; Chemokine CX3CL1/genetics ; Chemokine CX3CL1/metabolism
Academic Journal
Title:
A novel gene, TARDBP, and the protein it encodes can predict glioma patient prognosis and establish a prediction model.
Authors:
Fang X; Department of Neurosurgery, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
Wu F; Department of Orthopaedics and Traumatology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Jiang C; Department of Neurosurgery Intensive Care Unit, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. .
Show more
Source:
BMC neurology [BMC Neurol] 2023 May 06; Vol. 23 (1), pp. 182. Date of Electronic Publication: 2023 May 06.
Publication Type:
Journal Article
MeSH Terms:
Brain Neoplasms*/genetics
DNA-Binding Proteins*/genetics
Glioma*/genetics
Humans ; Mutation ; Prognosis
Academic Journal
Title:
Stalled oligodendrocyte differentiation in IDH-mutant gliomas.
Authors:
Wei Y; Department of Biology, Beijing Key Laboratory of Gene Resource and Molecular Development, School of Life Sciences, and Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, School of Life Sciences, Beijing Normal University, Beijing, China.
Li G; Beijing Neurosurgical Institute, Beijing, 100070, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Feng J; Department of Biology, Beijing Key Laboratory of Gene Resource and Molecular Development, School of Life Sciences, and Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, School of Life Sciences, Beijing Normal University, Beijing, China.
Wu F; Beijing Neurosurgical Institute, Beijing, 100070, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Zhao Z; Beijing Neurosurgical Institute, Beijing, 100070, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Bao Z; Beijing Neurosurgical Institute, Beijing, 100070, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Zhang W; Beijing Neurosurgical Institute, Beijing, 100070, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Su X; Biodynamic Optical Imaging Center (BIOPIC), School of Life Sciences, Peking University, Beijing, 100871, China.
Li J; College of Life Sciences, Sichuan Normal University, Chengdu, 610101, China.
Qi X; Department of Pathology, San Bo Brain Hospital, Capital Medical University, Beijing, 100093, China.
Duan Z; Department of Pathology, San Bo Brain Hospital, Capital Medical University, Beijing, 100093, China.
Zhang Y; Center of Growth Metabolism & Aging, Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, China.
Vega SF; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41390, Sweden.; Sahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41390, Gothenburg, Sweden.
Jakola AS; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 41390, Sweden.; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, 41390, Sweden.
Sun Y; Department of Biology, Beijing Key Laboratory of Gene Resource and Molecular Development, School of Life Sciences, and Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, School of Life Sciences, Beijing Normal University, Beijing, China.
Carén H; Sahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41390, Gothenburg, Sweden. .
Jiang T; Beijing Neurosurgical Institute, Beijing, 100070, China. .; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China. .; Chinese Glioma Genome Atlas Network (CGGA), Beijing, 100070, China. .
Fan X; Department of Biology, Beijing Key Laboratory of Gene Resource and Molecular Development, School of Life Sciences, and Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, School of Life Sciences, Beijing Normal University, Beijing, China. .; Chinese Glioma Genome Atlas Network (CGGA), Beijing, 100070, China. .
Show more
Source:
Genome medicine [Genome Med] 2023 Apr 13; Vol. 15 (1), pp. 24. Date of Electronic Publication: 2023 Apr 13.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Neoplasms*/metabolism
Glioma*/metabolism
Humans ; Isocitrate Dehydrogenase/genetics ; Cell Differentiation/genetics ; Oligodendroglia/metabolism ; Oligodendroglia/pathology ; Chromatin ; Mutation
Academic Journal
Title:
Association of RNA-modification "writer" genes with prognosis and response to immunotherapy in patients with low-grade glioma.
Authors:
Zhang L; Department of Biochemistry and Molecular Biology, Jishou University School of Medicine, Jishou, Hunan, China.
Qu C; Department of Statistics, College of Mathematics and Computer Science, Hunan Normal University, Changsha, Hunan, China.; School of Public Health and Management, Youjiang Medical University for Nationalities, Baise, Guangxi, China.
Shi C; Department of Biochemistry and Molecular Biology, Jishou University School of Medicine, Jishou, Hunan, China.
Wu F; Department of Biochemistry and Molecular Biology, Jishou University School of Medicine, Jishou, Hunan, China.
Tang Y; Department of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, China.
Li Y; Department of Pathology, Xiangtan Central Hospital, Xiangtan, China.
Li J; Department of Biochemistry and Molecular Biology, Jishou University School of Medicine, Jishou, Hunan, China.
Feng H; Department of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, China.
Zhong S; Department of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, China.
Yang J; Department of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, China.
Zeng X; Department of Epidemiology and Health Statistics, Xiangya Public Health School, Central South University, Changsha, Hunan, China.
Peng X; Department of Biochemistry and Molecular Biology, Jishou University School of Medicine, Jishou, Hunan, China.; Department of Statistics, College of Mathematics and Computer Science, Hunan Normal University, Changsha, Hunan, China.; Department of Pathology and Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan, China.
Show more
Source:
PloS one [PLoS One] 2023 Jan 17; Vol. 18 (1), pp. e0279119. Date of Electronic Publication: 2023 Jan 17 (Print Publication: 2023).
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glioma*/diagnosis
Glioma*/genetics
Glioma*/therapy
Humans ; Immunotherapy ; Nomograms ; Prognosis ; RNA ; Tumor Microenvironment/genetics
Academic Journal
Title:
The role m A RNA methylation is CNS development and glioma pathogenesis.
Authors:
Pan T; School of the Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.; Department of Gynecological Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China.
Wu F; School of the Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Li L; Department of Neurosurgery, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China.; Key Laboratory of Head & Neck Cancer, Translational Research of Zhejiang Province, Hangzhou, 310022, People's Republic of China.
Wu S; School of the Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.; Department of Gynecological Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China.
Zhou F; School of the Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.; Department of Gynecological Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China.
Zhang P; Department of Gynecological Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China. .
Sun C; Department of Neurosurgery, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China. .; Key Laboratory of Head & Neck Cancer, Translational Research of Zhejiang Province, Hangzhou, 310022, People's Republic of China. .
Xia L; Department of Neurosurgery, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China. .; Key Laboratory of Head & Neck Cancer, Translational Research of Zhejiang Province, Hangzhou, 310022, People's Republic of China. .
Show more
Source:
Molecular brain [Mol Brain] 2021 Jul 19; Vol. 14 (1), pp. 119. Date of Electronic Publication: 2021 Jul 19.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Adenosine/*analogs & derivatives
Central Nervous System/*embryology
Glioma/*genetics
RNA/*metabolism
Adenosine/metabolism ; Animals ; Glioma/pathology ; Humans ; Methylation ; Models, Biological
Academic Journal
Title:
A novel DNA repair-related nomogram predicts survival in low-grade gliomas.
Authors:
Li G; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Wu F; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Zeng F; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Zhai Y; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Feng Y; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Chang Y; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Wang D; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiang T; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.; Chinese Glioma Genome Atlas Network (CGGA), Asian Glioma Genome Atlas Network (AGGA).
Zhang W; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.; Chinese Glioma Genome Atlas Network (CGGA), Asian Glioma Genome Atlas Network (AGGA).
Show more
Source:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2021 Feb; Vol. 27 (2), pp. 186-195. Date of Electronic Publication: 2020 Oct 16.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nomograms*
Brain Neoplasms/*genetics
Brain Neoplasms/*mortality
DNA Repair/*genetics
Glioma/*genetics
Glioma/*mortality
Brain Neoplasms/diagnosis ; Female ; Follow-Up Studies ; Glioma/diagnosis ; Humans ; Male ; Neoplasm Grading/methods ; Neoplasm Grading/mortality ; Predictive Value of Tests
Academic Journal
Title:
Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas.
Authors:
Chai RC; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Chinese Glioma Genome Atlas (CGGA), Beijing, China.
Zhang KN; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Chinese Glioma Genome Atlas (CGGA), Beijing, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Liu YQ; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Chinese Glioma Genome Atlas (CGGA), Beijing, China.
Wu F; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Chinese Glioma Genome Atlas (CGGA), Beijing, China.
Zhao Z; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Chinese Glioma Genome Atlas (CGGA), Beijing, China.
Wang KY; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Chinese Glioma Genome Atlas (CGGA), Beijing, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiang T; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Chinese Glioma Genome Atlas (CGGA), Beijing, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang YZ; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.; Chinese Glioma Genome Atlas (CGGA), Beijing, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Show more
Source:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2019 Mar; Vol. 25 (3), pp. 314-322. Date of Electronic Publication: 2018 Aug 16.
Publication Type:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
CpG Islands*
Antineoplastic Agents, Alkylating/*therapeutic use
Brain Neoplasms/*metabolism
DNA Modification Methylases/*metabolism
DNA Repair Enzymes/*metabolism
Glioma/*metabolism
Temozolomide/*therapeutic use
Tumor Suppressor Proteins/*metabolism
Adult ; Aged ; Biomarkers, Tumor ; Brain Neoplasms/genetics ; Brain Neoplasms/therapy ; Cohort Studies ; DNA Methylation ; DNA Modification Methylases/genetics ; DNA Repair Enzymes/genetics ; Female ; Gene Expression ; Glioma/genetics ; Glioma/therapy ; Humans ; Male ; Middle Aged ; Prognosis ; Promoter Regions, Genetic ; RNA, Messenger/metabolism ; Tumor Suppressor Proteins/genetics ; Young Adult
Academic Journal
Title:
Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma.
Authors:
Wang W; Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Chinese Glioma Cooperative Group (CGCG), Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Wu F; Chinese Glioma Cooperative Group (CGCG), Beijing, China.; Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Zhao Z; Chinese Glioma Cooperative Group (CGCG), Beijing, China.; Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Wang KY; Chinese Glioma Cooperative Group (CGCG), Beijing, China.; Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Huang RY; Chinese Glioma Cooperative Group (CGCG), Beijing, China.; Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Wang HY; Chinese Glioma Cooperative Group (CGCG), Beijing, China.; Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Lan Q; Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Wang JF; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Chinese Glioma Cooperative Group (CGCG), Beijing, China.
Zhao JZ; Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Show more
Source:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2018 Oct; Vol. 24 (10), pp. 957-966. Date of Electronic Publication: 2018 Mar 25.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Neoplasms/*metabolism
Gene Expression Regulation, Neoplastic/*physiology
Glioma/*metabolism
RNA, Long Noncoding/*metabolism
Animals ; Brain Neoplasms/diagnosis ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Female ; Glioma/diagnosis ; Humans ; Kaplan-Meier Estimate ; Male ; Mice, Nude ; Microarray Analysis ; Neoplasm Invasiveness/genetics ; Prognosis ; Proportional Hazards Models ; RNA, Long Noncoding/genetics ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; Transduction, Genetic ; Xenograft Model Antitumor Assays
Academic Journal
Title:
ERCC1 polymorphisms and risk of adult glioma in a Chinese population: a hospital-based case-control study.
Authors:
Zhang N; Department of Neurosurgery, The Second Affiliated Hospital of Wenzhou Medical College, Zhejiang Province, China.
Lin LY
Zhu LL
Wu F
Wen H
Pan D
Huang YC
Chen DQ
Show more
Source:
Cancer investigation [Cancer Invest] 2012 Mar; Vol. 30 (3), pp. 199-202. Date of Electronic Publication: 2011 Dec 27.
Publication Type:
Journal Article
MeSH Terms:
Polymorphism, Genetic*
Asian People/*genetics
Brain Neoplasms/*genetics
DNA-Binding Proteins/*genetics
Endonucleases/*genetics
Glioma/*genetics
Adult ; Brain Neoplasms/etiology ; Case-Control Studies ; DNA Repair ; Female ; Genotype ; Glioma/etiology ; Humans ; Male ; Middle Aged ; Risk
Academic Journal
Title:
Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma
Authors:
Chai, Rui-ChaoAff1, Aff4, Aff6
Wang, Ning
Chang, Yu-Zhou
Zhang, Ke-NanAff1, Aff6
Li, Jing-JunAff1, Aff6
Niu, Jun-Jie
Wu, FanAff1, Aff6
Liu, Yu-QingAff1, Aff6
Wang, Yong-ZhiAff1, Aff3, Aff4, Aff6
Show more
Source:
Cancer Cell International. 19(1)
Academic Journal
Title:
Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
Authors:
Wu, FanAff1, Aff2, Aff3, Aff4
Zhao, ZhengAff1, Aff2, Aff3
Chai, RuichaoAff1, Aff2, Aff3
Liu, YuqingAff1, Aff2, Aff3
Wang, KuanyuAff1, Aff2, Aff3
Wang, ZhiliangAff1, Aff2, Aff3
Li, GuanzhangAff1, Aff2, Aff3
Huang, RuoyuAff1, Aff2, Aff3
Jiang, HaoyuAff1, Aff2, Aff3
Zhang, KenanAff1, Aff2, Aff3
Show more
Source:
Cancer Cell International. 18(1)
Academic Journal

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.